Short Chain Acyl CoA Dehydrogenase Deficiency (ICD-10-CM Code: E71.312)

Name of the Condition

• Short chain acyl CoA dehydrogenase deficiency.

Summary

Short chain acyl CoA dehydrogenase deficiency is an inherited metabolic disorder that impairs the body's ability to break down short-chain fatty acids for energy. This can lead to the accumulation of toxic byproducts, particularly during fasting or illness, and may cause symptoms affecting the liver, muscles, or nervous system. The condition disrupts normal metabolic pathways, potentially resulting in energy deficits or organ damage if untreated.

Causes

These disorders are caused by genetic mutations that affect enzymes or transport proteins involved in fatty-acid oxidation. Most are inherited in an autosomal recessive pattern, meaning both parents must carry a mutated gene for a child to be affected. The specific genetic defect determines the severity and clinical presentation of the condition.

Risk Factors

• Family history of fatty-acid oxidation disorders.
• Consanguineous relationships (parents who are closely related).
• Certain ethnic populations with higher carrier rates for specific mutations.

Symptoms

• Muscle weakness or pain, especially during exercise or fasting.
• Hypoglycemia (low blood sugar) or lethargy.
• Enlarged liver (hepatomegaly) or liver dysfunction.
• Neurological symptoms, such as seizures or developmental delays.
• Episodes of metabolic crisis during illness or prolonged fasting.

Diagnosis

Diagnosis typically involves clinical evaluation, biochemical testing (e.g., acylcarnitine profile, organic acid analysis), and genetic testing to confirm the presence of pathogenic variants in the ACADS gene. Newborn screening may detect elevated markers, prompting further investigation. Additional tests, such as enzyme activity assays or muscle biopsies, may be used to support the diagnosis in some cases.

Treatment Options

Management focuses on preventing metabolic crises through dietary modifications, such as avoiding prolonged fasting and ensuring regular carbohydrate intake. Emergency protocols for acute episodes may include intravenous glucose and supportive care. Long-term treatment may involve tailored dietary plans, supplements, or medications to manage symptoms and prevent complications. Regular monitoring by a metabolic specialist is essential.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the condition and adherence to treatment. Early diagnosis and strict management can improve outcomes, reducing the risk of acute crises and long-term complications. Follow-up care includes regular metabolic evaluations, nutritional counseling, and monitoring for organ function or developmental delays. Lifelong management is typically required.

Complications

• Recurrent metabolic crises leading to organ damage.
• Neurological impairment, including seizures or developmental delays.
• Liver dysfunction or failure.
• Muscle weakness or rhabdomyolysis.
• Growth delays or failure to thrive in severe cases.

Lifestyle & Prevention

• Maintain a consistent eating schedule to avoid fasting.
• Follow a diet rich in complex carbohydrates and balanced nutrients.
• Stay hydrated and avoid excessive physical exertion without adequate fueling.
• Carry emergency medical information or supplies (e.g., glucose gel) for unexpected situations.
• Educate caregivers, schools, or workplaces about the condition and emergency protocols.

When to Seek Professional Help

Seek immediate medical attention if experiencing symptoms of hypoglycemia, lethargy, vomiting, or altered mental status, especially during illness or fasting. Contact a healthcare provider for routine follow-up or if new symptoms (e.g., muscle pain, jaundice) develop. Emergency care is critical for signs of metabolic crisis.

Tips for Medical Coders

Document the clinical context, including symptoms, diagnostic tests, and management plans, to support code assignment. Ensure specificity in documentation (e.g., acute vs. chronic episodes, treatment adherence) to align with coding guidelines. Note that E71.312 is specific to short chain acyl CoA dehydrogenase deficiency; avoid using broader codes unless the documentation does not specify the subtype.